Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Vaccines against Ebola remain an urgent global health priority and outbreaks continue, notably the ongoing outbreak in North Kivu in the DRC.

In this study published in the Journal of Infectious Diseases, scientists from the Jenner Institute and IRESSEF in Senegal showed that combining two new vaccines against Ebola was safe and induced strong immune responses

Read the full article